Home Other Building Blocks (7R,8S,9S,10R,13R,14S,17R)-7-Hydroxy-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one

(7R,8S,9S,10R,13R,14S,17R)-7-Hydroxy-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one

CAS No.:
3862-25-7
Catalog Number:
AG00C9GN
Molecular Formula:
C27H44O2
Molecular Weight:
400.6371
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$416
- +
Product Description
Catalog Number:
AG00C9GN
Chemical Name:
(7R,8S,9S,10R,13R,14S,17R)-7-Hydroxy-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
CAS Number:
3862-25-7
Molecular Formula:
C27H44O2
Molecular Weight:
400.6371
MDL Number:
MFCD00870345
IUPAC Name:
(7R,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
InChI:
InChI=1S/C27H44O2/c1-17(2)7-6-8-18(3)21-9-10-22-25-23(12-14-27(21,22)5)26(4)13-11-20(28)15-19(26)16-24(25)29/h15,17-18,21-25,29H,6-14,16H2,1-5H3/t18-,21-,22+,23+,24-,25+,26+,27-/m1/s1
InChI Key:
IOIZWEJGGCZDOL-RQDYSCIWSA-N
SMILES:
CC(CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2[C@H](O)CC2=CC(=O)CC[C@]12C)C)C
Properties
Complexity:
663  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
8  
Defined Bond Stereocenter Count:
0
Exact Mass:
400.334g/mol
Formal Charge:
0
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
400.647g/mol
Monoisotopic Mass:
400.334g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
37.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
7.3  
Literature
Title Journal
The rate-determining steps of aldo-keto reductases (AKRs), a study on human steroid 5β-reductase (AKR1D1). Chemico-biological interactions 20150605
Expression of CYP3A in chronic ethanol-fed mice is mediated by endogenous pregnane X receptor ligands formed by enhanced cholesterol metabolism. Archives of toxicology 20150401
Cholestatic effect of epigallocatechin gallate in rats is mediated via decreased expression of Mrp2. Toxicology 20130107
Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20120901
Dietary fish oil increases fat absorption and fecal bile acid content without altering bile acid synthesis in 20-d-old weanling rats following massive ileocecal resection. Pediatric research 20120701
Lipoprotein distribution and serum concentrations of 7α-hydroxy-4-cholesten-3-one and bile acids: effects of monogenic disturbances in high-density lipoprotein metabolism. Clinical science (London, England : 1979) 20120401
Gender, but not CYP7A1 or SLCO1B1 polymorphism, affects the fasting plasma concentrations of bile acids in human beings. Basic & clinical pharmacology & toxicology 20120301
Bile Acid signaling in liver metabolism and diseases. Journal of lipids 20120101
Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice. PloS one 20120101
Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humans. Digestion 20120101
Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. The American journal of gastroenterology 20111201
Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19. Journal of internal medicine 20111201
New insights into bile acid malabsorption. Current gastroenterology reports 20111001
The immune system in irritable bowel syndrome. Journal of neurogastroenterology and motility 20111001
Monitoring of 7α-hydroxy-4-cholesten-3-one during therapy of cerebrotendinous xanthomatosis: a case report. Chemistry and physics of lipids 20110901
Bile acid signaling after an oral glucose tolerance test. Chemistry and physics of lipids 20110901
Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers. Inflammatory bowel diseases 20110601
An evaluation of the use of serum 7-alpha-hydroxycholestenone as a diagnostic test of bile acid malabsorption causing watery diarrhea. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20110601
The effect of disease associated point mutations on 5β-reductase (AKR1D1) enzyme function. Chemico-biological interactions 20110530
Enteric microbiome metabolites correlate with response to simvastatin treatment. PloS one 20110101
Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitus. PloS one 20110101
Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology 20101101
Quantification of the 15 major human bile acids and their precursor 7α-hydroxy-4-cholesten-3-one in serum by liquid chromatography-tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20101015
Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder. Expert review of gastroenterology & hepatology 20101001
On the mechanism of accumulation of cholestanol in the brain of mice with a disruption of sterol 27-hydroxylase. Journal of lipid research 20100901
Characterization of disease-related 5beta-reductase (AKR1D1) mutations reveals their potential to cause bile acid deficiency. The Journal of biological chemistry 20100806
Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. Biochemical and biophysical research communications 20100521
The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. American journal of physiology. Gastrointestinal and liver physiology 20100301
Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20100201
Regulation of diurnal variation of cholesterol 7alpha-hydroxylase (CYP7A1) activity in healthy subjects. Physiological research 20100101
ESI-MS/MS quantification of 7alpha-hydroxy-4-cholesten-3-one facilitates rapid, convenient diagnostic testing for cerebrotendinous xanthomatosis. Clinica chimica acta; international journal of clinical chemistry 20100101
A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20091101
Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20090701
Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans. Pharmacogenetics and genomics 20090601
Increased NPC1L1 and ACAT2 expression in the jejunal mucosa from Chinese gallstone patients. Biochemical and biophysical research communications 20090130
Biliary sphincterotomy does not relate to diarrhoea or major changes in bile acid synthesis or plasma lipids. Scandinavian journal of gastroenterology 20090101
Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients. Lipids in health and disease 20090101
Crystal structures of human Delta4-3-ketosteroid 5beta-reductase (AKR1D1) reveal the presence of an alternative binding site responsible for substrate inhibition. Biochemistry 20081223
CYP7A1 promoter polymorphism -203A>C affects bile salt synthesis rate in patients after ileal resection. Journal of lipid research 20081201
Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment. The British journal of nutrition 20081101
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients. Steroids 20081001
The crystal structure of human Delta4-3-ketosteroid 5beta-reductase defines the functional role of the residues of the catalytic tetrad in the steroid double bond reduction mechanism. Biochemistry 20080812
Improved HPLC analysis of serum 7alpha-hydroxycholest-4-en-3-one, a marker of bile acid malabsorption. Clinical chemistry 20080601
Decreased bile acid synthesis with total parenteral nutrition. American journal of surgery 20071101
Novel LC-MS/MS method for assay of 7alpha-hydroxy-4-cholesten-3-one in human plasma. Evidence for a significant extrahepatic metabolism. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070901
Oat bran rapidly increases bile acid excretion and bile acid synthesis: an ileostomy study. European journal of clinical nutrition 20070801
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression. European journal of clinical investigation 20070601
On the mechanism of cerebral accumulation of cholestanol in patients with cerebrotendinous xanthomatosis. Journal of lipid research 20070501
Increased activity of hepatic microsomal triglyceride transfer protein and bile acid synthesis in gallstone disease. Hepatology (Baltimore, Md.) 20070501
Highly sensitive quantification of 7alpha-hydroxy-4-cholesten-3-one in human serum by LC-ESI-MS/MS. Journal of lipid research 20070201
In silico prediction of pregnane X receptor activators by machine learning approaches. Molecular pharmacology 20070101
Analysis of ileal sodium/bile acid cotransporter and related nuclear receptor genes in a family with multiple cases of idiopathic bile acid malabsorption. World journal of gastroenterology 20061221
Budesonide treatment is associated with increased bile acid absorption in collagenous colitis. Alimentary pharmacology & therapeutics 20061201
Species differences among various rodents in the conversion of 7alpha-hydroxycholesterol in liver microsomes. Steroids 20060501
Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. European journal of gastroenterology & hepatology 20060401
Biliary lipids, cholesterol and bile synthesis: different adaptive mechanisms to dietary cholesterol in lean and obese subjects. Alimentary pharmacology & therapeutics 20060401
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. European journal of clinical investigation 20060301
An isocratic high-performance liquid chromatography assay for CYP7A1-catalyzed cholesterol 7alpha-hydroxylation. Methods in molecular biology (Clifton, N.J.) 20060101
Rapeseed oil, olive oil, plant sterols, and cholesterol metabolism: an ileostomy study. European journal of clinical nutrition 20051201
Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. Gastroenterology 20051101
Pituitary control of cholesterol metabolism in normal and LDL receptor knock-out mice: effects of hypophysectomy and growth hormone treatment. Biochimica et biophysica acta 20051001
Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentration. Atherosclerosis 20050901
Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 20050801
Comparison of efficacy of plant stanol ester and sterol ester: short-term and longer-term studies. The American journal of cardiology 20050704
High serum phytosterol levels in short bowel patients on parenteral nutrition support. Clinical nutrition (Edinburgh, Scotland) 20050601
Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis. Journal of lipid research 20050201
Lipoprotein metabolism in patients with anorexia nervosa: a case-control study investigating the mechanisms leading to hypercholesterolaemia. The British journal of nutrition 20040601
Influence of rifampin on serum markers of cholesterol and bile acid synthesis in men. International journal of clinical pharmacology and therapeutics 20040601
Bile acid synthesis is increased in Chilean Hispanics with gallstones and in gallstone high-risk Mapuche Indians. Gastroenterology 20040301
Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humans. Arteriosclerosis, thrombosis, and vascular biology 20040201
Significance of plasma 7alpha-hydroxy-4-cholesten-3-one and 27-hydroxycholesterol concentrations as markers for hepatic bile acid synthesis in cholesterol-fed rabbits. Metabolism: clinical and experimental 20040101
Effects of ursodeoxycholic acid on synthesis of cholesterol and bile acids in healthy subjects. Digestion 20040101
Assay method for mitochondrial sterol 27-hydroxylase with 7alpha-hydroxy-4-cholesten-3-one as a substrate in the rat liver. Journal of lipid research 20031201
Origin of oxysterols in hepatic bile of patients with biliary infection. The American journal of gastroenterology 20031001
25-Hydroxylation of vitamin D3 in primary cultures of pig hepatocytes: evidence for a role of both CYP2D25 and CYP27A1. Biochemical and biophysical research communications 20030411
Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood. Journal of lipid research 20030401
Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance. Proceedings of the National Academy of Sciences of the United States of America 20030204
Selective inhibition of CYP27A1 and of chenodeoxycholic acid synthesis in cholestatic hamster liver. Biochimica et biophysica acta 20021120
A comparative study of the conversion of 7-hydroxycholesterol in rabbit, guinea pig, rat, hamster, and chicken. Steroids 20020701
Bowel habits and bile acid malabsorption in the months after cholecystectomy. The American journal of gastroenterology 20020701
Prolonged stimulation of the adrenals by corticotropin suppresses hepatic low-density lipoprotein and high-density lipoprotein receptors and increases plasma cholesterol. Endocrinology 20020501
Cholesterol catabolism in patients with acute myelogenous leukemia and hypocholesterolemia: suppressed levels of a circulating marker for bile acid synthesis. Cancer letters 20010920
Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects. Hepatology (Baltimore, Md.) 20010501
Determinants of variable response to statin treatment in patients with refractory familial hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology 20010501
Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX. Journal of lipid research 20010201
Properties